Clinical Trial Update: Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation (RFA) Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining immune profile and prognosis of malignant liver tumors following radiofrequency ablation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Liver Cancer | Phase 4 | Status: COMPLETED